Introduction {#s1}
============

Because multicellular organisms often face disturbances in their homeostasis, they evolved complex immune responses to deal with sterile and infectious insults. Like elsewhere in the human body, immune cells differentiate from multipotent precursors. In the immune context, precursors are primarily hematopoietic stem cells in the bone marrow. One of these differentiation programs, called granulopoiesis, leads to the development of granulocytes - basophils, eosinophils and neutrophils. Neutrophils are the most abundant leukocytes in humans. In homeostatic conditions, up to 2 × 10^11^ neutrophils enter the blood stream per day and patrol the host's body until they sense signs of infection, which triggers them to leave the blood stream and migrate to the inflammatory site where they ensure pathogen removal. An efficient neutrophil response is crucial for human antimicrobial defense and, correspondingly, neutropenia is associated with severe infections ([@bib26]).

The three best described defense mechanisms of neutrophils are phagocytosis (engulfment of pathogenic microorganisms and subsequent destruction in phagosomes), degranulation (the release of antimicrobial proteins from granules to the extracellular space) and the formation of neutrophil extracellular traps (NETs). NETs are chromatin structures studded with antimicrobial proteins derived mostly from neutrophil granules, which can trap pathogens ([@bib32]). Neutrophils release NETs via various mechanisms, which in most cases lead to neutrophil death ([@bib24]); thus, NETs are an extreme form of antimicrobial defense, as their release also eliminates the cell casting the NET. Under homeostatic conditions, NET formation occurs in mature, circulating neutrophils and therefore we propose that specific cues during neutrophil differentiation shape their ability to form NETs. It is noteworthy that during systemic inflammation, some neutrophils, called low density granulocytes, display signs of immaturity, but enhanced formation of NETs ([@bib7]; [@bib45]). In inflammatory settings the requirement for full differentiation might therefore be less stringent.

Neutrophils differentiate from granulocyte-macrophage precursors. The first progenitor with a clear neutrophil lineage preference during granulopoiesis is the promyelocyte ([@bib51]). During maturation, neutrophils acquire a lobulated nuclear shape and produce many of their antimicrobial effector proteins, stored in granules ([@bib5]). Granulopoiesis requires balanced activity of various transcription factors ([@bib51]). The C/EBP family, especially C/EBP-α and --ε, are key regulators of neutrophil differentiation ([@bib52]; [@bib48]). Other transcription factors can antagonize C/EBP-dependent neutrophil development. For example, expression of GATA-1 ([@bib49]) and GATA-2 ([@bib18]) induce eosinophil, basophil or mast cell differentiation ([@bib13]).

Differentiation programs rely both on transcription factor activation and on epigenetic chromatin alterations. DNA wraps around an octamer of core histones forming a nucleosome. The linker histone H1 binds to nucleosomes and further compacts chromatin ([@bib4]). There are 11 different H1 subtypes in mice and humans. Five of them (H1.1 -- H1.5) are somatic replication-dependent subtypes, two (H1.0 and H1X) are somatic and replication-independent and four (H1oo, H1t, H1T2 and HILS1) are germline-specific ([@bib17]). All H1 subtypes consist of a highly conserved globular domain and two more variable regions: the N- and the C-terminal tails. Individual H1 subtypes are more conserved between species than H1 subtypes are within one species, suggesting that the conservation of different subtypes has functional relevance ([@bib17]). Still, some functions of H1, such as global shaping of chromatin structure, are redundant between subtypes. This is reflected by the fact that mice deficient for one or even two H1 subtypes are viable and fertile without striking morphological abnormalities ([@bib11]). However, mice lacking three H1 subtypes die in utero, with total H1 levels reduced to about 50% ([@bib11]). Appropriate H1 expression is therefore essential for development. Despite some redundancy, H1 subtypes have specific functions. H1 subtypes bind to chromatin with different affinities and knock down of specific H1 subtypes affects gene transcription in distinct ways ([@bib16]; [@bib43]; [@bib37]).

The role of H1 and H1 subtypes in immunity is poorly understood. H1 contributes to the silencing of pro-inflammatory cytokines after endotoxin challenge ([@bib10]), as well as to the silencing of interferon-stimulated genes ([@bib23]). Interestingly, mice deficient in H1.0 have fewer dendritic cells, but normal numbers of granulocytes, macrophages and lymphocytes, showing a subtype-specific role for H1 in dendritic cell differentiation ([@bib15]). However, to date, no studies have systematically addressed H1 subtype involvement in the maturation and function of human immune cells.

Here we used the human neutrophil-like cell line, PLB-985, to study neutrophil maturation and function. We performed a genome-wide CRISPR/Cas9 screen using survival to a NET-inducing stimulus, phorbol 12-myristate 13-acetate (PMA), as a readout. Surprisingly, we found that depletion of either H1.2 or H1.4 strongly reduced the differentiation of PLB-985 and thereby their ability to form NETs. Notably, deficiency of the other somatic H1 subtypes, H1.1, H1.3 and H1.5, accelerated PLB-985 maturation. RNA-seq analysis showed that H1.2 and H1.4 deficiency leads to an upregulation of eosinophil genes in PLB-985. Mirroring these results, murine bone marrow stem cells from H1.2/H1.4 double deficient mice shifted their differentiation profile from neutrophil towards eosinophil cell fate, whereas neutrophils in vivo displayed disturbances in ageing markers. We further demonstrate that the subtype-specific function of H1 in neutrophil and eosinophil differentiation depends -- at least in part -- on the transcription factor GATA-2. We uncovered that, unexpectedly, H1 subtypes affect lineage specification during granulopoiesis.

Results {#s2}
=======

PLB-985: a model for neutrophil maturation and function {#s2-1}
-------------------------------------------------------

We used the human promyelocytic cell line PLB-985 ([@bib44]). PLB-985 differentiate into neutrophil-like cells that resemble primary human neutrophils in various ways ([@bib54]; [@bib33]; [@bib34]; [@bib28]). PLB-985 changed their nuclear morphology and developed granules, though fewer than primary neutrophils, throughout the 7 days of differentiation (referred as d0 to d7 in this report) ([Figure 1a](#fig1){ref-type="fig"}). Once differentiated, PLB-985 also produced ROS in response to the agonist phorbol 12-myristate 13-acetate (PMA) ([Figure 1b](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1a](#fig1s1){ref-type="fig"}) and upregulated the surface marker CD11b ([Figure 1c](#fig1){ref-type="fig"}). Furthermore, differentiated PLB-985 phagocytosed *Escherichia coli*, a process that could be blocked by the phagocytosis inhibitor cytochalasin B ([Figure 1---figure supplement 1b](#fig1s1){ref-type="fig"}). Importantly, PMA potently induced cell death in fully differentiated PLB-985, but not in d0 or d3 cells ([Figure 1d](#fig1){ref-type="fig"}). PMA-induced cell death was morphologically similar to NETosis; dying PLB-985 expanded their nuclei and a significant fraction released DNA as shown by SYTOX Green staining ([Figure 1e](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1c](#fig1s1){ref-type="fig"}). Of note, the calcium ionophore A23187, another stimulant of NET formation, also induced cell death in PLB-985, both at d3 and d7 of differentiation ([Figure 1---figure supplement 1d](#fig1s1){ref-type="fig"}). Taken together, these experiments show that PLB-985 cells differentiate into neutrophil-like phagocytes that produce ROS and NETs.

![A genome-wide screen to identify genes required for PLB-985 cells differentiation and function.\
(**a--d**) Characterization of PLB-985 differentiation and function at d0, d3 and 7 of differentiation. (**a**) Electron microscopy images of PLB-985 showing acquisition of granules (green arrows, the black arrow at d0 indicates mitochondria) and changes in nuclear morphology. Scale bars correspond to 5 μm. (**b**) ROS production of PLB-985 in response to 100 nM PMA, showing that only fully differentiated PLB-985 produced an oxidative burst. (**c**) Surface expression of CD11b, depicted is the percentage of CD11b positive cells out of all viable singlets. (**d**) PMA-induced cell death was measured over time after addition of the cell-impermeable DNA dye SYTOX Green and analysis of fluorescence indicating cell death. 'd7 naïve' indicates differentiated cells, which were not treated with PMA. (**e**) Representative images of differentiated PLB-985 (**d7**) after addition of SYTOX Green and treatment with or without PMA. Scale bars are 20 μm. (**f**) Outline of the CRISPR/Cas9 screen. Cells were transduced with a genome-wide CRISPR/Cas9 library (lentiviral particles, small circles), differentiated for 7 days, treated with PMA for 16 hr and survivors were sorted and sequenced to identify sgRNAs. (**g**) Top 10 of the screen, H1.2 (*HIST1H1C*) and indicated genes with known neutrophil functions, ranked first by % of overrepresented guides and then by median overrepresentation and mapped to a proteome list of human primary neutrophils. (**b--d**) Depicted are mean -/+ SEM of 3 independent experiments.\
Figure 1---source data 1.List of genes identified as hits in the CRISPR/Cas9 screen.The table shows gene ID and the fold representation of identified sgRNAs in PMA-treated versus untreated PLB-985. sgRNAS that were not identified in either sample are labelled as NA. The table also shows the median and mean values per gene and the percentage of overrepresented (at least two fold) sgRNAs.](elife-52563-fig1){#fig1}

To show that PLB-985 can be genetically modified by CRISPR/Cas9, we disrupted expression of NOX2 (*CYBB*), a component of the NADPH oxidase complex, which is required for PMA-induced NETosis ([@bib14]). We also transduced PLB-985 with a non-target scrambled single-guide RNA (sgRNA) as a control (subsequently called scr.). Differentiated PLB-985 cells lacking NOX2 failed to produce an oxidative burst and did not undergo cell death in response to PMA ([Figure 1---figure supplement 1e,f](#fig1s1){ref-type="fig"}). To inactivate NADPH oxidase independently of NOX2, we also disrupted expression of its NCF2 subunit, and showed again that these cells did not die upon PMA stimulation ([Figure 1---figure supplement 1g](#fig1s1){ref-type="fig"}). These results demonstrate that PLB-985, which can be genetically modified, are a suitable model to mimic human neutrophils.

A genome-wide screen to identify regulators of neutrophil maturation and function {#s2-2}
---------------------------------------------------------------------------------

We found that PMA-induced NET formation required full differentiation of PLB-985. Therefore, we used this readout to perform a genome-wide CRISPR/Cas9 screen to identify genes required for neutrophil maturation and function ([Figure 1f](#fig1){ref-type="fig"}). We reasoned that, besides NET-defective cells, we could also identify differentiation-defective cells by sorting cells that survived PMA treatment. We transduced PLB-985 with a library targeting all human genes with 5--6 sgRNAs per gene ([@bib41]). As expected, PMA stimulation reduced the fraction of identified guides in the survivor population ([Figure 1---figure supplement 1h](#fig1s1){ref-type="fig"}), indicating selection of specific clones.

We defined 'hits' as genes for which at least 50% of the identified sgRNAs were overrepresented (more than two-fold) in our survivor population. Underlining the validity of the screening approach, we identified *CYBB*, *NCF1* and *MPO* as hits; all three are known to be required for PMA-induced NET formation ([@bib14]; [@bib30]; [Figure 1g](#fig1){ref-type="fig"}, [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). We also found *CEBPD*, a member of the C/EBP family of transcription factors that are crucial for granulopoiesis ([@bib46]; [Figure 1g](#fig1){ref-type="fig"}). Unexpectedly, we identified two members of the linker histone H1 family among the 20 highest ranked genes. *HIST1H1E* (H1.4) was overrepresented with 100% of sgRNAs and showed the highest median enrichment ([Figure 1g](#fig1){ref-type="fig"}, [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). Notably, there are no studies showing a functional role of H1 in neutrophil differentiation or NET formation.

H1.4 and H1.2 affect neutrophil function through differentiation {#s2-3}
----------------------------------------------------------------

There are five somatic replication-dependent (H1.1 -- H1.5) and two replication-independent H1 subtypes (H1.0 and H1X). PLB-985 expressed mRNA encoding H1.2 and H1.4 more abundantly than the other subtypes ([Figure 2a](#fig2){ref-type="fig"}). The expression of replication-dependent H1 subtypes occurs mainly in the S phase of proliferating cells and, accordingly, H1 mRNA levels decreased during PLB-985 differentiation ([Figure 2---figure supplement 1a](#fig2s1){ref-type="fig"}, same experiments as in [Figure 2a](#fig2){ref-type="fig"}, but plotted as relative to d0). As expected, this reduction was more evident for subtypes with a higher baseline expression ([Figure 2a](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1a](#fig2s1){ref-type="fig"}). When we looked at H1.2 and H1.4 protein expression of PLB-985 during differentiation, we found that protein levels also decreased as the cells matured ([Figure 2---figure supplement 1b](#fig2s1){ref-type="fig"}).

![H1.2 and H1.4 are required for PLB-985 differentiation.\
(**a**) mRNA expression levels of indicated H1 subtypes (nomenclature refers to protein names) in PLB-985 cells at d0, d3 and d7 of differentiation, relative to the housekeeping gene β-microglobulin, depicted is the mean -/+ SEM of 3 independent experiments. (**b**) mRNA expression levels of indicated H1 subtypes in human primary neutrophils, relative to β-microglobulin. Data points are from four different donors, error bars are mean -/+ SEM. (**c**) PMA-induced cell death of wild type (wt) scrambled sgRNA (non-target, scr.) and two clones of either H1.2 or H1.4 over time, measured by SYTOX Green fluorescence. Depicted are mean -/+ SEM of 5 independent experiments of cells at d7 of differentiation. (**d**) Measurement of PMA-induced ROS production from wt, scr. and H1.2 or H1.4 deficient PLB-985, depicted are mean -/+ SEM of 5 independent experiments at d7 of differentiation. (**c, d**) wt and scr. values are the same in the left and right panels, respectively. (**e**) Western blot of lysates of PLB-985 at d3 of differentiation, showing efficient disruption of H1.2 and H1.4 (both antibodies recognize the other subtype, which is marked by a red asterisk for H1.2 and a blue asterisk for H1.4) as well as reduced MPO expression, the core histone H3 served as loading control.](elife-52563-fig2){#fig2}

We also analyzed two datasets comparing mRNA and protein expression of human primary bone marrow cells undergoing differentiation into neutrophils at various stages of maturation, namely myelocytes, metamyelocytes, band form neutrophils and segmented neutrophils ([@bib1]; [@bib19]) (see Materials and methods section for RNA-seq). Consistent with our PLB-985 data, we found a similar reduction of H1 mRNA as maturation progressed ([Figure 2---figure supplement 1c](#fig2s1){ref-type="fig"}). The protein levels of H1 subtypes in these datasets remained relatively stable during differentiation, despite a reduction in mRNA ([Figure 2---figure supplement 1c,d](#fig2s1){ref-type="fig"}). Hence, all H1 subtypes are expressed in differentiating primary neutrophils and although the mRNA levels decrease over time of differentiation, the protein levels seem to be relatively stable.

mRNA levels of each H1 subtypes were still detectable in differentiated PLB-985 and primary cells. Accordingly, human primary neutrophils isolated from blood of healthy donors expressed detectable amounts of the H1 genes. H1.2 and H1.4, the two hits in our genome wide screen, were the most abundantly expressed subtypes ([Figure 2b](#fig2){ref-type="fig"}). Interestingly, peripheral blood mononuclear cells (PBMCs) and monocytes showed a slightly different expression pattern of this gene family than neutrophils ([Figure 2---figure supplement 1e,f](#fig2s1){ref-type="fig"}).

To verify the results from our screen, we disrupted expression of H1.2 and H1.4 in PLB-985 by targeting these genes with CRISPR/Cas9. We used two clones deficient for H1.2 (from two sgRNAs) and two clones deficient for H1.4 (from one sgRNA) in our analysis. Cell death was reduced in both H1.2 and H1.4-deficient clones, confirming the results of the screen ([Figure 2c](#fig2){ref-type="fig"}). H1.2 and H1.4-deficient clones produced ROS less efficiently than wild type cells upon PMA stimulation ([Figure 2d](#fig2){ref-type="fig"}). Furthermore, cells deficient for either of the two H1 subtypes expressed less MPO ([Figure 2e](#fig2){ref-type="fig"}). Cells deficient for H1.2 or H1.4 could still phagocytose, demonstrating that not all effector functions were equally affected by the loss of H1 subtypes ([Figure 2---figure supplement 1g,h](#fig2s1){ref-type="fig"}). These findings suggest that H1.2 and H1.4 are required for PLB-985 to differentiate into mature, neutrophil-like cells.

Opposing effects of H1 subtypes on neutrophil differentiation {#s2-4}
-------------------------------------------------------------

To confirm that deficiency of H1.2 and H1.4 affected PLB-985 maturation, we showed that surface expression of the differentiation marker CD11b is decreased on both d3 and d7 of differentiation ([Figure 3a,b](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1a,b](#fig3s1){ref-type="fig"}) in cells where these genes were deleted. We also disrupted expression of the other three somatic H1 subtypes. Surprisingly, loss of these subtypes resulted in the opposite phenotype. We observed markedly enhanced expression of CD11b already at d3, especially in clones deficient in H1.1 and H1.5 ([Figure 3a,b](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1a,b](#fig3s1){ref-type="fig"}). To test whether these effects were specific to neutrophilic cells, we also disrupted expression of H1 subtypes in the monocytic cell line THP-1 and analyzed their ability to release IL-1β via the NLRP3 inflammasome. Batch populations of H1-deficient cells released similar amounts of IL-1β than control cells when activated with silica crystals ([Figure 3---figure supplement 1c](#fig3s1){ref-type="fig"}). We therefore conclude that loss of H1 subtypes does not generally impact myelopoiesis or innate immune functions.

![H1 effects on PLB-985 differentiation are subtype-specific.\
(**a, b**) Expression of the surface marker CD11b at d3 (**a**) or d7 (**b**) of differentiation. Depicted is the percentage of CD11b-positive cells out of all living singlets for wt, scrambled (scr.) and two knockout clones per H1 subtype. (**c, d**) Growth curves of PLB-985 during differentiation (**c**) and cell counts at d7 of differentiation (**d**) show restricted growth of H1.1, H1.3 and H1.5-deficient cells and enhanced growth of H1.2 and H1.4-deficient clones. (**a--d**) Depicted are five independent experiments, error bars are SEM. (**e, f**) Viability, as determined by DAPI negative cells, at d8 (**e**) and d12 (**f**) of differentiation of 3 independent experiments. Error bars are SEM.](elife-52563-fig3){#fig3}

Differentiation of neutrophils and PLB-985 is terminal - if not activated, these cells die by apoptosis. The number of wild type and control (scr.) PLB-985 cells increased more from d0 to d3 than from d3 to d7. This suggests that cells withdrew from proliferation ([Figure 3c](#fig3){ref-type="fig"}). Interestingly, H1.2 and H1.4-deficient clones grew unrestrictedly until d7, whereas cells deficient in H1.1, H1.3 and H1.5 decreased in comparison to controls ([Figure 3c,d](#fig3){ref-type="fig"}). Furthermore, control cells successively lost viability from d8 to d12 ([Figure 3e,f](#fig3){ref-type="fig"}). In line with their enhanced growth, H1.2 and H1.4-deficient cells were more viable than controls, whereas H1.1, H1.3 and H1.5-deficient cells showed less viability than controls ([Figure 3e,f](#fig3){ref-type="fig"}). Of note, cells deficient in H1.1 had a stronger oxidative burst in response to PMA than control cells, consistent with enhanced maturation ([Figure 3---figure supplement 1d](#fig3s1){ref-type="fig"}). Clones deficient in H1.3 and H1.5, on the other hand, produced less ROS than control cells ([Figure 3---figure supplement 1e,f](#fig3s1){ref-type="fig"}). This could be a specific effect of H1.3 and H1.5, but it could also reflect reduced viability at the onset of the experiment. In summary, these experiments show an unexpected and opposing effect of H1 subtypes on PLB-985 cell differentiation and function.

The impact of H1 deficiency manifests before onset of differentiation {#s2-5}
---------------------------------------------------------------------

To understand the extent of H1 subtype-specific effects on neutrophil differentiation we performed RNA-sequencing of the knockout lines. We sampled wild type cells, scr. cells and two clones per H1 subtype at d0, d3 and d7 of differentiation in four independent experiments ([Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}). To validate the applicability of our experiment, we compared the transcriptome of control PLB-985 cells (the combination of wild type and scr. samples) to human primary cells at various differentiation stages towards neutrophils ([@bib1]) (also see Materials and methods section). Gene set enrichment analysis demonstrated that PLB-985 and primary cells concordantly regulate processes during differentiation ([Figure 4a](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1a,b](#fig4s1){ref-type="fig"}. [Figure 4---figure supplement 1a](#fig4s1){ref-type="fig"} depicts the same analysis as [Figure 4a](#fig4){ref-type="fig"} with the gene set labels). Using principal component analysis (PCA), we saw that these cells follow a similar differentiation trajectory ([Figure 4---figure supplement 1c](#fig4s1){ref-type="fig"}). As expected, among the most robustly upregulated genes during differentiation of control cells we found several with known functions in neutrophils ([Figure 4b](#fig4){ref-type="fig"}).

![RNA-seq reveals H1 subtype-specific effects on differentiation and an eosinophilic signature of undifferentiated H1.2/H1.4 knockout lines.\
(**a**) Concordantly and discordantly regulated genes when comparing PLB-985 differentiation (wt and scr., d0 to d7) and human neutrophil differentiation (Blueprint, neutrophilic myelocyte to segmented neutrophil of bone marrow) using discordance scores and tmod. Most modules are concordantly regulated. (**b**) Volcano plot of all differentially expressed genes of control cells (wt and scr.) between d7and d0, darker gray depicts p\<0.05 and logFC \>2. A selection of strongly upregulated genes is labelled and neutrophil markers are highlighted in red. Expression of granule proteins, such as MPO, neutrophil elastase (*ELANE*), proteinase 3 (*PRTN3*) and cathepsin G (*CTSG*) decreases during differentiation. (**c**) Principal component analysis (PCA) of control and mutant PLB-985 during differentiation shows clustering according to experimental replicates and genotypes and separates samples according to differentiation state. Lines indicate the center-of-mass trajectory for 'normal' (wild type and scr. cells), 'hyper' (H1 clones with enhanced differentiation) and 'hypo' (H1 clones with reduced differentiation) samples. While lines deficient in H1.1, H1.3 and H1.5 already at d3 cluster closely to wt and scr. at d7, indicating faster and more efficient differentiation, H1.2 and H1.4-deficient clones at d7 still only cluster with wt and scr. at d3, indicating a stalled development.(**d**) Scatter dot plot depicting differentially expressed genes of H1.2 knockouts vs control cells at d0 of differentiation (x axis) and H1.4 knockouts vs control cells at d0 of differentiation (y axis), color (alpha) indicates p-value of differential expression between H1.2 and H1.4 at d0. Neutrophil genes such as neutrophil elastase (*ELANE*), proteinase 3 (*PRTN3*), cathepsin G (*CTSG*), azurocidin (*AZU1*) and *MPO* are strongly downregulated in both conditions when compared to wt and scr., whereas eosinophil genes such as galectin 10 (*CLC*), interleukin-5 receptor alpha (*IL5RA*), GATA-1 (*GATA1*), GATA-2 (*GATA2*) or eosinophil peroxidase (*EPX*) are upregulated. (**e**) Gene set enrichment analysis of indicated samples at d0 of differentiation shows enhanced expression of eosinophil and GATA-1 gene sets (see Materials and methods) in H1.2 and H1.4-deficient lines, but not in other knockout conditions.\
Figure 4---source data 1.RNA-seq expression tables.The individual sheets display expression values of indicated conditions (Cont. is wild type and scr. combined, for the respective H1 subtypes values of 2 clones are combined).](elife-52563-fig4){#fig4}

We analyzed the H1-deficient clones by PCA and found that H1.2 and H1.4-deficient clones at d7 clustered more closely with control cells at d3, indicating delayed differentiation ([Figure 4c](#fig4){ref-type="fig"}). H1.1, H1.3 and H1.5-deficient cells at d3 clustered with control cells at d7, suggesting accelerated differentiation ([Figure 4c](#fig4){ref-type="fig"}).

Analysis of the enrichment of gene modules confirmed that, during differentiation, control cells upregulated genes related to the innate immune response and downregulated genes corresponding to cell cycle and division, in line with the context of terminal differentiation ([Figure 4---figure supplement 1d](#fig4s1){ref-type="fig"}). Interestingly, in H1.2 and H1.4-deficient cells, the modules were less regulated, again demonstrating prolonged proliferation and obstruction of differentiation ([Figure 4---figure supplement 1d](#fig4s1){ref-type="fig"}). We performed the same analysis for clones deficient in H1.1, H1.3 and H1.5 and confirmed accelerated differentiation ([Figure 4---figure supplement 1d](#fig4s1){ref-type="fig"}). We subsequently asked whether absence of H1 subtypes also affected the determination and lineage choice of PLB-985 before differentiation. To address this question, we compared differentially expressed genes of H1.2 and H1.4-deficient cells and control cells at d0. We found that both H1.2 and H1.4-deficient cells downregulated neutrophil genes, such as *MPO* and neutrophil proteases among others ([Figure 4d](#fig4){ref-type="fig"}), indicating that lineage fate was affected in undifferentiated cells.

Surprisingly, among the upregulated genes we found a significant number of genes associated with eosinophils and a GATA-1 signature ([Figure 4d,e](#fig4){ref-type="fig"}, see Materials and methods section for the source of datasets). We found this upregulation specifically in clones deficient in H1.2 and H1.4 in comparison to all other genotypes ([Figure 4e](#fig4){ref-type="fig"}). This suggests that loss of H1.2 and H1.4 affects lineage determination of PLB-985 cells even before the onset of differentiation by driving them towards a more eosinophil-like fate. Notably, we also saw dysregulation of C/EBP family transcription factors in cells deficient for different H1 subtypes ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). We found downregulation of *CEBPA* in cells deficient for H1.2 and H1.4 at d0, but upregulation of the same transcription factors in cells deficient for H1.1, H1.3 and H1.5 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). This is in line with decreased and enhanced maturation, respectively. Other C/EBP family members also showed dysregulated expression patterns in H1-deficient clones ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Our data indicate that H1 subtype depletion affects both cell fate determination and differentiation per se.

Enhanced eosinophil differentiation of H1.2/H1.4-deficient hematopoietic stem cells {#s2-6}
-----------------------------------------------------------------------------------

Loss of H1.2 and H1.4 appears to bias the lineage commitment of PLB-985 away from neutrophils via regulation of an eosinophil-like transcriptional program. We therefore analyzed the morphology of these cells by transmission electron microscopy. There was no obvious morphological difference between genotypes ([Figure 4---figure supplement 3a](#fig4s3){ref-type="fig"}). However, loss of H1.2 and H1.4 led to enhanced expression of the eosinophil marker Siglec-8 on the surface of a subset of PLB-985 ([Figure 4---figure supplement 3b](#fig4s3){ref-type="fig"}). H1.2- and H1.4-deficient PLB-985 also expressed higher levels of the eosinophil protein galectin-10/CLC, in line of what we had seen by RNA-seq ([Figure 4---figure supplement 3c,d](#fig4s3){ref-type="fig"}). We therefore conclude that even though PLB-985 do not become fully functional eosinophils in our differentiation system, H1.2 and H1.4 deficiency leads to enhanced expression of some eosinophil proteins. We also looked at H1 mRNA expression levels in human primary eosinophils and found that these cells expressed very high levels of H1.2 and H1.4 ([Figure 4---figure supplement 3e](#fig4s3){ref-type="fig"}). A proteomics dataset of cells in circulation confirmed high expression levels of H1 subtypes in eosinophils ([Figure 4---figure supplement 3f](#fig4s3){ref-type="fig"}; [@bib35]), suggesting that eosinophil maturation relies on an appropriate amount of H1 subtype expression during differentiation.

To test whether this eosinophil bias also exists in primary cells, we analyzed cells isolated from H1.2/H1.4 double-deficient mice ([@bib11]). The profile of circulating lymphocytes and monocytes in the blood or bone marrow of adult animals was indistinguishable from wild type animals ([Figure 5---figure supplements 1](#fig5s1){ref-type="fig"} and [2](#fig5s2){ref-type="fig"}). Furthermore, wild type and H1.2/H1.4-deficient animals had the same proportion of neutrophils in circulation and in bone marrow ([Figure 5a,b](#fig5){ref-type="fig"}, [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"} and [2](#fig5s2){ref-type="fig"}). We also induced a sterile peritonitis in these animals by injection of casein into the peritoneal cavity ([@bib52]). 24 hr upon injection the numbers of circulating leukocytes and bone marrow leukocytes were similar between genotypes ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}).

![Deletion of H1.2 or H1.4 biases murine hematopoietic cells towards an eosinophil lineage.\
(**a--c**) Analysis of circulating neutrophils and eosinophils in wild type (wt) and H1.2/H1.4-double deficient mice (H1.2/H1.4 -/-). p Values, derived from unpaired two-tailed T tests, are indicated. (**a**) Flow cytometry analysis of neutrophils (Gr1 positive, CD115 negative) in whole blood of adult age-matched animals (wt n = 15, H1.2/H1.4 - / - n = 14), other immune cell types are shown in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. (**b**) Flow cytometry analysis of absolute amounts of neutrophils (Ly-6G positive cells) in whole blood (n = 4). (**c**) Flow cytometry analysis of amounts of eosinophils (SiglecF positive) in whole blood (n = 4). H1.2/H1.4 - / - animals show enhanced eosinophil numbers in circulation. **d-f** Lineage-negative hematopoietic stem cells were sorted from murine bone marrow and cultured for 6 days in the presence of various cytokines allowing differentiation into several immune cell lineages. Depicted are CD11b positive cells (**d**) and the fraction of neutrophils (**e**) or eosinophils (**f**) within CD11b-positive cells. Each dot represents an independent experiment consisting of two mice per genotype, the mean of the two wild type animals was set to one and the mean of the two H1.2/H1.4 - / - animals is depicted relative to wt. (**a--f**) Error bars are SEM.](elife-52563-fig5){#fig5}

Importantly, although the number of eosinophils in the bone marrow were similar between genotypes ([Figure 5---figure supplement 4a](#fig5s4){ref-type="fig"}), H1.2/H1.4-deficient animals had enhanced amounts of circulating eosinophils during homeostasis, suggesting that, in vivo, there is also bias towards eosinophils ([Figure 5c](#fig5){ref-type="fig"}). The number of circulating neutrophils returned to the same level as in wildtype animals upon casein injection ([Figure 5---figure supplement 4b,c](#fig5s4){ref-type="fig"}). In addition to a change in eosinophil numbers in circulation, H1.2/H1.4-deficient mice showed disturbances in neutrophil ageing markers ([@bib53]; [@bib2]). We found similar expression of CD62L in bone marrow neutrophils during homeostasis, but a slightly lower number of CD62L+ CXCR4- 'young' neutrophils ([@bib53]; [@bib2]) in H1.2/H1.4-deficient mice ([Figure 5---figure supplement 5a--c,g](#fig5s5){ref-type="fig"}). Upon casein injection, we found more CD62L+, but also more CXCR4+ neutrophils in wildtype than in H1.2/H1.4-deficient animals ([Figure 5---figure supplement 5d--f,h](#fig5s5){ref-type="fig"}). These results suggest a slight disturbance of neutrophil ageing upon H1 deficiency. Interestingly, we also found altered expression of cytokines and chemokines. H1.2/H1.4-deficient bone marrow cells expressed enhanced levels of the chemokine CXCL1, reduced amounts of *IL6* mRNA, and we also found enhanced levels of IL-17 upon casein injection ([Figure 5---figure supplement 6a--d](#fig5s6){ref-type="fig"}). IL-17 affects granulopoiesis via G-CSF ([@bib42]). Upon casein injection, the levels of G-CSF were similar between wild type and H1.2/H1.4-deficient animals ([Figure 5---figure supplement 6e](#fig5s6){ref-type="fig"}). However, the response of bone marrow cells to G-CSF was altered upon loss of H1.2/H1.4; these cells were more viable after overnight incubation in the presence of G-CSF than wild type cells ([Figure 5---figure supplement 7a](#fig5s7){ref-type="fig"}). Furthermore, bone marrow cells of H1.2/H1.4-deficient mice were more granular than wild type cells, which could reflect reduced spontaneous degranulation or differentially aged cells ([@bib3]; [Figure 5---figure supplement 7b](#fig5s7){ref-type="fig"}). We also looked at the granularity of neutrophils in circulation and in the bone marrow of animals during homeostatic and inflammatory conditions. H1.2/H1.4-deficient neutrophils were more granular in the bone marrow, both during homeostasis and upon casein injection, but not in circulation ([Figure 5---figure supplement 7c,d](#fig5s7){ref-type="fig"}). Taken together, we concluded that the altered cytokine and chemokine milieu in these mice might lead to compensatory effects on the maturation of neutrophils in vivo.

To analyze the intrinsic differentiation potential of H1.2/H1.4-deficient cells in the absence of confounding factors, we isolated lineage negative cells from murine bone marrow and differentiated them into several lineages ([@bib6]). Importantly, H1.2/H1.4-deficient cells expressed elevated levels of surface markers for eosinophils and decreased levels of neutrophil surface markers, as compared to wild type cells. This recapitulates the phenotype we observed in PLB-985 ([Figure 5d--f](#fig5){ref-type="fig"}). These experiments show that H1.2 and H1.4 cooperate to determine the neutrophil-eosinophil cell fate decision in hematopoietic progenitor cells. Furthermore, our findings suggest that, in vivo, the H1.2 and H1.4 deficiency is compensated by a different turnover of neutrophils and by a dysregulated cytokine milieu to generate normal amounts of neutrophils during homeostasis. Importantly, the bias towards eosinophils also exists in vivo, demonstrating that loss of H1.2 and H1.4 affects the eosinophil lineage determination.

Loss of H1.2 and H1.4 affect neutrophil cell fate determination via GATA-2 {#s2-7}
--------------------------------------------------------------------------

Two transcription factors required for eosinophil differentiation, GATA-1 and GATA-2, were upregulated on mRNA level in H1.2 and H1.4 knockout lines ([Figure 4d](#fig4){ref-type="fig"}). *GATA2* transcripts were higher than *GATA1* and transcript levels of both transcription factors at d0 inversely correlated with the potential of PLB-985 to adopt a neutrophil-like cell fate ([Figure 6---figure supplement 1a,b](#fig6s1){ref-type="fig"}). Interestingly, in mice *GATA1* mRNA expression was higher than *GATA2*, and we could also see enhanced expression of *GATA1* in H1.2/H1.4-deficient bone marrow cells as compared to wild type cells ([Figure 6---figure supplement 1c](#fig6s1){ref-type="fig"}). Expression of *GATA2* did not change in H1.2/H1.4-deficient murine cells, but we saw a slight downregulation of *CEBPA*, which is in line with the expression profiles of PLB-985 ([Figure 6---figure supplement 1d,e](#fig6s1){ref-type="fig"}).

We speculated that H1 subtypes affect neutrophil differentiation through either GATA-1 or GATA-2. To test this hypothesis, we disrupted expression of GATA-1 and GATA-2 by CRISPR/Cas9 in PLB-985 and analyzed batch populations of various mutations at d4 of differentiation. We chose d4 because we assumed that cells still expressing GATA could outgrow GATA-deficient cells at later time points. Interestingly, GATA-2 deficiency enhanced maturation of PLB-985, as indicated by an increased ability to produce ROS in response to PMA ([Figure 6---figure supplement 2a](#fig6s2){ref-type="fig"}). In contrast, GATA-1 knockout lines behaved as scr. cells ([Figure 6---figure supplement 2a](#fig6s2){ref-type="fig"}).

To test whether the differentiation phenotype of H1.2 and H1.4-deficient lines relied on GATA-2, we performed a rescue experiment by generating double-deficient lines. We transduced scr. cells and H1.2 or H1.4-deficient cells with GATA-1 and GATA-2 sgRNAs or with a scr. sgRNA as a control and analyzed these populations at d4. Importantly, disruption of GATA-2 expression rescued ROS production ([Figure 6a--c](#fig6){ref-type="fig"}) and CD11b expression ([Figure 6d](#fig6){ref-type="fig"}) in H1.2 and H1.4-deficient PLB-985. Again, disruption of GATA-1 had no effect ([Figure 6a--d](#fig6){ref-type="fig"}). These experiments demonstrate that the differentiation phenotype resulting from H1.2 and H1.4 deficiency depends on upregulation of GATA-2 and, importantly, that loss of GATA-2 is sufficient to allow differentiation in the absence of these H1 subtypes.

![Deficiency of H1.2 or H1.4 is rescued by inhibition of GATA-2.\
(**a--c**) Deficiency in GATA-2 but not GATA-1 rescues H1.2 and H1.4 deficiency. Populations are batches of PLB-985. scr. (**a**), H1.4 (**b**) and H1.2 (**c**) knockout lines were transduced with an sgRNA against *GATA1* or *GATA2* or with a scr. sgRNA as control and analyzed for ROS production in response to PMA at d4 of differentiation. (**d**) Deficiency in GATA-2 rescues CD11b expression of H1.2 and H1.4-deficient PLB-985. CD11b expression of the indicated genotypes was measured at d4 of differentiation. (**e**) Treatment of PLB-985 with GATA-2 but not GATA-1 inhibitor rescues expression of CD11b, especially in lines deficient in H1.2 and H1.4. (**f--k**) ROS production of PLB-985 in response to PMA is affected upon GATA-2, but not GATA-1 inhibition during differentiation. (**f--k**) PLB-985 ROS production was measured at d7 of differentiation, indicated genotypes were treated with indicated inhibitors or solvent before the onset of differentiation and at d4. (**a--k**) Shown is the mean -/+ SEM of 3 independent experiments.](elife-52563-fig6){#fig6}

In a second approach, we treated PLB-985 with inhibitors for GATA-1 and GATA-2, starting treatment one day before differentiation. Inhibition of GATA-2 enhanced CD11b expression of H1.2 or H1.4-deficient lines ([Figure 6e](#fig6){ref-type="fig"}). To confirm the effect of GATA-2 inhibition on differentiation, we measured mRNA expression of two genes, one that increased (aquaporin-9, *AQP9*) and one that decreased (*MPO*) during differentiation ([Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}). As expected, H1.2 and H1.4-deficient lines expressed less *AQP9* and more *MPO* than scr. cells at d7 of differentiation ([Figure 6---figure supplement 2b,c](#fig6s2){ref-type="fig"}). GATA-2 inhibition upregulated expression of *AQP9* and downregulated expression of *MPO* in H1.2 and H1.4 knockout lines at d7 of differentiation, indicating a rescue of maturation ([Figure 6---figure supplement 2b,c](#fig6s2){ref-type="fig"}). In line with our results with CRISPR/Cas9-mediated gene disruption, GATA-2 inhibition restored the capacity of H1.2 and H1.4-deficient clones to mount an oxidative burst ([Figure 6f--h](#fig6){ref-type="fig"}). As expected, treatment with the GATA-1 inhibitor did not affect maturation and function of PLB-985 of either genotype ([Figure 6e,i--k](#fig6){ref-type="fig"}). The combination of GATA-1 and GATA-2 inhibitors did not have an additive effect on PLB-985 maturation, confirming that GATA-2 is the relevant transcription factor for the phenotype observed in H1.2 and H1.4-deficient clones in the human cell system ([Figure 6---figure supplement 2d](#fig6s2){ref-type="fig"}). Importantly, the response to either GATA-2 deficiency or inhibition was stronger in H1-deficient PLB-985 than in scr. cells. This is in line with enhanced baseline expression of the transcription factor in H1.2 or H1.4-deficient clones. These data show that H1.2 and H1.4 affect fate determination and subsequent neutrophil differentiation and function at least partly through the regulation of GATA-2.

Discussion {#s3}
==========

We identified an unexpected role of H1 subtypes in neutrophil development; loss of H1.2 and H1.4 inhibits differentiation while deficiency in H1.1, H1.3 and H1.5 enhances it. We propose that in neutrophil precursors, H1 subtypes control the expression or activity of GATA-2, which determines cell fate via transcription of neutrophil or eosinophil-specific genes. Enhanced expression of eosinophil genes -- or reduced expression of neutrophil-specific genes -- disrupts normal maturation, leading to prolonged proliferation and viability and reduced neutrophil function. Consistent with this, genetic ablation or inhibition of GATA-2, but not GATA-1, rescued the differentiation of H1.2 and H1.4-deficient cells. Interestingly, another study found that overexpression of GATA-2 in murine progenitor cells switched their lineage determination from macrophages to a megakaryocyte state ([@bib25]). GATA-2 therefore acts as a key molecule for fate determination of immune cells.

It is noteworthy that we found evidence of enhanced *GATA1* mRNA expression in bone marrow cells of H1.2/H1.4-deficient mice, but not of *GATA2*. The fold change of *GATA1* in the absence of H1.2 and H1.4 was much higher in PLB-985 than the fold change of *GATA2*. Furthermore, in mice *GATA1* mRNA was higher expressed than *GATA2* mRNA. This could explain why we did not see an upregulation of *GATA2* in vivo. Another explanation could be that *GATA2* upregulation does not occur in lineage negative stem cells, but during the promyelocyte to neutrophil differentiation, while the regulation of *GATA1* is more robust. Enforced expression of both GATA-1 and GATA-2 can induce eosinophil differentiation of human CD34+ hematopoietic stem cells ([@bib18]). Interestingly, another study in murine cells showed that the eosinophil-promoting effect of GATA-2 depends strongly on the presence of C/EBP-α. Enforced expression of GATA-2 drove C/EBP-α expressing precursor cells into the eosinophil lineage. However, in the absence of C/EBP-α, overexpression of GATA-2 induced mast cell and basophil development ([@bib20]). Therefore, not only the expression levels of hematopoietic transcription factors, but also the order of their expression is crucial for lineage determination. PLB-985 express C/EBP-α in the undifferentiated state, and enhanced expression of GATA-2 can therefore explain the upregulation of eosinophil markers we found in our experiments using this cell line.

Importantly, we observed a preference for eosinophil development in blood and in hematopoietic stem cells isolated from the bone marrow of H1.2/H1.4-deficient mice. This demonstrates that the bias towards the eosinophilic lineage also exists in vivo. However, adult H1.2/H1.4-deficient animals had normal numbers of circulating neutrophils, indicating that neutrophil differentiation is compensated. Interestingly the turnover rate or the longevity of neutrophils seemed to be affected in these mice, since we found reduced amounts of young neutrophils in H1.2/H1.4-deficient animals. We also found enhanced granularity and longevity of neutrophils isolated from H1.2/H1.4-deficient animals. These two findings, reduced levels of CD62L (a marker of young neutrophils) and enhanced granularity, are not consistent with the paradigm of young neutrophils being more granular ([@bib3]). Our data therefore point to a dysregulation of neutrophil behavior and/or turnover. Interestingly, however, the protein levels of H1.2 and H1.4 changed in human neutrophils during the time of day, suggesting that linker histone levels might affect neutrophil ageing in vivo ([@bib3]).

Neutropenia in peripheral tissues triggers de novo production of neutrophils in the bone marrow ([@bib42]), demonstrating that granulopoiesis in vivo is regulated by feedback loops. This suggests that initial neutrophil deficiency in adult H1.2/H1.4-deficient mice is compensated by a different cytokine milieu. In line with this, we found altered expression of various cytokines and chemokines, thus suggesting a dysregulated turnover or production of neutrophils in H1.2/H1.4-deficient mice. It is noteworthy that we did not detect differences in the major cytokine driving neutrophil differentiation, G-CSF. Casein-induced peritonitis upregulated G-CSF in both wt and H1.2/H1.4-deficient animals. The serum levels of G-CSF during homeostasis were very low and probably under the detection limit of our ELISA, and, if there are minor differences in G-CSF levels, we were not able to measure them. We did, however, detect differences in the neutrophil-recruiting chemokine CXCL1 and in the pro-inflammatory cytokine IL-17, which could both also affect neutrophil turnover and behavior.

Interestingly, in human breast cancer cells, combined loss of H1.2 and H1.4 leads to an upregulation of an interferon signature ([@bib21]). Although we did not observe an obvious interferon signature in H1.2 or H1.4-deficient PLB-985, it is possible that in H1.2/H1.4-deficient mice some cell types contribute to immune cell differentiation via interferon-stimulated genes.

H1 can act in redundant and subtype-specific ways ([@bib17]). Mice lacking one or two H1 subtypes are viable and fertile ([@bib11]). Analogously, PLB-985 deficient in any of the five H1 subtypes that we disrupted were viable and did not show growth defects. This is in contrast to another study, where shRNA-mediated knock down of H1.2 and H1.4 reduced cell growth and viability in various non-immune cell lines ([@bib37]). We found that loss of H1.2 and H1.4, in the context of neutrophil differentiation, enhanced viability, demonstrating cell type specific effects of H1 subtypes.

H1 has long been considered a general repressor of transcription ([@bib39]). Accordingly, a study in human cells found that genomic regions associated with active transcription were devoid of H1 subtypes ([@bib22]). However, murine embryonic stem cells that are triple-deficient in H1.2, H1.3 and H1.4 show a surprisingly low number of only 38 differentially expressed genes when compared to wild type cells ([@bib12]). Our data show that loss of H1 subtypes in more differentiated cells affects the expression of many genes with clear functional consequences. We postulate that only a fraction of differentially expressed genes in PLB-985 is directly regulated by H1 subtypes. The enhanced expression of lineage-determining transcription factors, such as GATA-2, leads to further changes in the transcriptome and affects cell differentiation.

An important open question is: how do H1 subtypes control expression of GATA-2? It is possible that H1 subtypes directly occupy the promoter or enhancer elements of *GATA2* and silence its expression. H1 subtype-specific binding to genomic regions has, for example, been shown for human H1.5 ([@bib27]). Interestingly, H1.5 targeted over 20-fold more regions in differentiated human lung fibroblasts than in embryonic stem cells and H1.5 binding led to chromatin compaction and gene silencing. It is therefore tempting to speculate that similar mechanisms are at play during neutrophil development. In addition to a direct repressive effect of H1.5, its binding to chromatin was also associated with an enrichment of demethylation of histone H3 at lysine 9 (H3K9me2) ([@bib27]). H3K9me2 is a posttranslational modification of a core histone that is associated with a repressive chromatin state. H1 subtypes are therefore likely to regulate transcription via epigenetic marks on core histones. Furthermore, H1 subtypes themselves are posttranslationally modified in a subtype-specific manner ([@bib17]). Although less is known about H1 modifications than about core histones, it is likely that such modifications can determine subtype-specific protein-protein interactions, chromatin binding properties or other features that subsequently cause transcriptional changes.

It is puzzling that vertebrates express so many different H1 subtypes. Although they are able to compensate each other in 'extreme' situations, such as the loss of one or even two subtypes in a whole organism ([@bib11]), they may also have more subtle and specific functions. This study contributes to our understanding of how different H1 subtypes initiate distinct transcriptional programs. Importantly, these programs appear to be evolutionarily conserved, since we found similar responses in human and murine cells.

Our observations in the human cell line PLB-985 and murine stem cells ex vivo correlate with an increase in the number of circulating eosinophils in H1.2/H1.4-deficient mice in vivo. We also detected a disturbed cytokine milieu and a dysregulation of neutrophil ageing markers, granularity and longevity in H1.2/H1.4-deficient animals, suggesting altered neutrophil turnover. This would be in line with altered expression levels of H1.4 and H1.2 during human neutrophil ageing in circulation ([@bib3]).

Notably, the number of neutrophils in the bone marrow and in circulation in H1.2/H1.4-deficient mice was normal. Moreover, eosinophil numbers in bone marrow were the same between genotypes. Taking all these observations and limitations together, we propose that H1 subtype regulation in vivo is subject to compensatory mechanisms that eventually adjust the levels of neutrophils. Indeed, it is expected that deletion of 2 out of 5 H1 subtypes, that probably affect the epigenetic regulation of development, are subject to systemic adjustments. Further in vivo work, ideally also aimed at investigating possible species differences between human and mouse, will likely elucidate the relevance of H1 deficiency on granulopoiesis and neutrophil turnover in vivo during homeostasis and inflammation.

In summary, we identified novel and opposing functions for specific H1 subtypes in granulopoiesis. H1 subtypes affect the lineage determination between neutrophils and eosinophils. We speculate that inappropriate expression of H1 subtypes in the hematopoietic compartment shapes pathologies with neutrophil or eosinophil involvement, such as asthma. Our findings suggest that linker histones represent another layer of complexity to the fascinating process of immune cell differentiation.

Materials and methods {#s4}
=====================

Cell lines {#s4-1}
----------

PLB-985 were kindly provided by Prof. Mary Dinauer, Washington University School of Medicine ([@bib54]). THP-1 were from DSMZ-German Collection of Microorganisms and cell cultures. The cell lines were authenticated by STR authentication (eurofins Genomics); PLB-985 and THP-1 wildtype strains were mycoplasma negative (eurofins Genomics). The generated knockout lines were not routinely tested for mycoplasma.

Antibodies and staining reagents {#s4-2}
--------------------------------

H1.2 antibody (PA5-32009, Invitrogen), H1.4 antibody (41328S, Cell Signaling), GAPDH antibody (Cell Signaling, 2118), MPO antibody (A0398, Dako), Histone H3 antibody (ab1791, Abcam), galectin-10 antibody (Abcam, 231964), SYTOX Green nucleic acid stain (Thermo Fisher Scientific) and 4′,6-diamidino-2-phenylindole (DAPI; Sigma) were used. All flow cytometry antibodies were from BD Biosciences: human CD11b (557321), human Siglec-8 (347105), mouse CD11b (562605), mouse Ly-6G (551461), mouse SiglecF (565527), mouse CD45 (561487), mouse CD3 (561798), mouse CD4 (552775), mouse CD8a (561093), mouse CD115 (565249), mouse GR1 (561103).

Chemicals and cytokines {#s4-3}
-----------------------

Luminol (11050, AAT-Bioquest), horseradish peroxidase (31941, Serva), PMA (P8139, Sigma), A23187 (Santa Cruz Biotechnology Inc), GATA-1 inhibitor (anagrelide, SML0846, Sigma), GATA-2 inhibitor (K-7174, HY-12743A, MedChemExpress) were used. Recombinant murine cytokines (IL-3, IL-5, IL-9, GM-CSF, SCF, G-CSF) were from Peprotech.

Plasmids {#s4-4}
--------

All CRISPR/Cas9 gene disruptions were done using lentiCRISPRv2 ([@bib41]; [@bib38]). LentiCRISPRv2 was a gift from Feng Zhang (Addgene plasmid \#52961; <http://n2t.net/addgene>:52961; RRID:[Addgene_52961](https://scicrunch.org/resolver/Addgene_52961)). Lentiviral particles were produced using psPAX and pMD2.G packaging plasmids in HEK293T cells.

sgRNA sequences and primers {#s4-5}
---------------------------

All sgRNA sequences and primer sequences are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Donor consent {#s4-6}
-------------

Human primary neutrophils, eosinophils, PBMCs and monocytes were isolated from blood samples of healthy volunteers according to the declaration of Helsinki. All donors provided written informed consent and all blood samples were collected from blood donated anonymously and with approval from the ethics committee--Charité --Universitätsmedizin Berlin (EA1/0104/06).

Mice {#s4-7}
----

Breeding of mice and isolation of blood and bone marrow were approved by the Berlin state authority Landesamt für Gesundheit und Soziales (license numbers for breeding: ZH161, ZH122, license numbers for isolation of cells: T0049/18, license number for injection of casein: H0085/18). All mice were bred at the Max Planck Insitute for Infection Biology under specific pathogen-free conditions. Animals were maintained on a 12 hr light/12 hr dark cycle and fed ad libitum. H1.2/H1.4-deficient animals were provided by Prof. Arthur Skoultchi ([@bib11]). Casein injection was performed as described ([@bib52]). Briefly, mice were injected intraperitoneally with 1 ml of 7% casein in the evening and again 12 hr later. 3 hr after the second injection, animals were sacrificed and blood as well as bone marrow was isolated for analysis.

Primary cell isolation {#s4-8}
----------------------

Neutrophils were purified by centrifugation of whole blood over Histopaque-1119 (Sigma), followed by centrifugation over a discontinuous Percoll gradient ([@bib52]). PBMCs were collected from the upper phase after Histopaque-1119 centrifugation, washed and either used for RNA extraction or for isolation of monocytes by positive selection (CD14) with magnetic beads (130-050-201, Miltenyi Biotec). Eosinophils were isolated from full blood using an isolation kit according to the manufacturer's instructions (130-092-010, Miltenyi Biotec).

PLB-985 propagation and differentiation {#s4-9}
---------------------------------------

PLB-985 were cultured in RPMI (RPMI 1640 medium, gibco) supplemented with 10% FCS, L-glutamine and antibiotics (25030--024 and 15140--122, gibco), cells were passaged every 3--4 days. For differentiation, cells were counted at d0 and 0.4 × 10^6^ cells/ml were seeded in differentiation medium (RPMI supplemented with 2.5% FCS, 0.5% dimethylformamide (DMF, D4551, Sigma), L-glutamine and antibiotics), usually in six well plates in a total volume of 3 ml. At d4 of differentiation, 2 ml of differentiation medium were added per six well. At d7, cells were washed and passed over an equal volume of Histopaque-1077 (Sigma) (centrifugation for 20 min at 800 x g, brakes off) to remove debris and subsequently seeded at the required density for experiments in assay medium (RPMI (without phenol red) containing 1% FCS, 0.5% DMF and L-glutamine).

Transmission electron microscopy {#s4-10}
--------------------------------

Cell suspensions, fixed in 2.5% glutaraldehyde, were sedimented and embedded in low melting agarose (2% in PBS). Drops of agarose containing cells were then postfixed in 0,5% osmiumtetroxide, contrasted with tannic acid and 2% uranyl acetate, dehydrated in a graded ethanol series and embedded in epoxy resin. After polymerization, sections were cut at 60 nm and contrasted with lead citrate. Specimens were analyzed in a Leo 906E transmission electron microscope at 100KV (Zeiss, Oberkochen, DE) using a side mounted digital camera (Morada; SIS-Olympus Münster DE).

Analysis of ROS production from cells {#s4-11}
-------------------------------------

Cells were seeded at 10^5^/well of a white 96 well plate (Nunc) in triplicates in a final volume of 100 μl in assay medium. HRP (1.2 U/ml) and luminol (50 μM) were added 10 min after seeding and 10 min later cells were stimulated with 100 nM PMA. Luminescence signal was measured using a VICTOR XLight Multimode Plate Reader (Perkin Elmer).

Analysis of cell death {#s4-12}
----------------------

Cells were seeded at 10^5^/well of a 96 well plate in duplicates or triplicates in a final volume of 100 μl. The cell impermeable DNA dye SYTOX Green (50 nM) was added and 10 min later cells were stimulated with 100 nM PMA or with 5 μM A23187. SYTOX Green fluorescence signal corresponding to NET formation and cell death was measured over time using excitation/emission of 485/518 nm. Alternatively, microscopy pictures were acquired using brightfield and GFP channels (for SYTOX Green) in order to visualize the morphology of dead cells.

Analysis of phagocytosis {#s4-13}
------------------------

PLB-985 at d7 of differentiation were seeded at 5 × 10^5^ in a final volume of 20 μl and stimulated with a multiplicity of infection (MOI) 5 of fluorescently labelled (GFP-expressing or Alexa Fluor 488 conjugated) *E. coli* (Thermo Fisher Scientific). After incubation for 30 min at 37°C on a shaker (300 rpm), the cells were washed twice with PBS and acquired by flow cytometry for the uptake of bacteria.

Analysis of surface marker expression {#s4-14}
-------------------------------------

PLB-985 and murine ex vivo differentiated bone marrow cells were stained at various time points of differentiation with indicated surface marker antibodies for 20 min at 4°C in PBS with 2% FCS, washed and analyzed by flow cytometry using a MACS Quant Analyzer (Miltenyi Biotec). DAPI was added just before acquisition to exclude dead cells.

Murine blood was stained the same way as described above, but after staining, samples were incubated with eBioscience 1 Step Fix/Lyse Solution (invitrogen, 00-5333-54) for 1 hr to lyse erythrocytes before acquisition.

CRISPR/Cas9 screen {#s4-15}
------------------

PLB-985 were transduced with a lentiviral library containing CRISPR/Cas9 sgRNAs ([@bib41]) at an estimated MOI of \<1. Cells were selected with puromycin (Sigma, 2.5 μg/ml), differentiation was performed as described for wt PLB-985. At d7 of differentiation, cells were stimulated with 100 nM PMA for 16 hr and surviving cells were sorted by FACS. DNA extraction was performed by DNeasy Blood and Tissue Kit (Qiagen) and PCR amplification was performed as described ([@bib41]). Reads were mapped to the library and abundance of sgRNAs was calculated per condition. Genes with greater than 50% of their sgRNAs identified at values of at least 2-fold overrepresentation in the PMA-treated group versus the control group were defined as hits.

Generation of CRISPR/Cas9 knockout lines {#s4-16}
----------------------------------------

PLB-985 were transduced with lentiviral particles containing the sgRNA of interest cloned into lentiCRISPRv2, cells were selected with puromycin (2.5 μg/ml) and, if single clones were analyzed, seeded at a density of 0.8 cells/well in 96 wells for limited dilution cloning. Clones were sequenced using the OutKnocker protocol and software ([@bib40]; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Clones with out of frame indels leading to efficient gene disruption were used for subsequent experiments.

For GATA-1 and GATA-2 disruption in scr., H1.2 and H1.4-deficient cells, sgRNAs targeting GATA were cloned into a modified lentiCRISPRv2, in which the Cas9 sequence was exchanged for a blasticidin resistance cassette. After transduction, cells were selected with blasticidin (50 μg/ml) and used in batch populations for experiments.

RNA extraction and qRT-PCR {#s4-17}
--------------------------

Cell samples were pelleted, resuspended and lysed in TRIzol Reagent (life technologies). RNA was isolated by chloroform extraction and isopropanol precipitation. Similar amounts of total RNA were used for RT-PCR (High Capacity cDNA Reverse Transcription Kit, 4368814, Thermo Fisher Scientific). qRT-PCR was performed using SYBR Green (4385612, Thermo Fisher Scientific) on a QuantStudio 3(Thermo Fisher Scientific).

RNA-sequencing {#s4-18}
--------------

Total RNA of PLB-985 at various time points was isolated using RNeasy kit (Qiagen). Library preparation and illumina sequencing were performed by the Max Planck-Genome-centre Cologne, Germany (<https://mpgc.mpipz.mpg.de>). The data were mapped to hg38.87 using STAR 2.5.2b ([@bib8]) and differential expression analysis was performed using edgeR ([@bib29]). Gene level read counts from primary human cells at various steps of neutrophil differentiation were retrieved from Blueprint ([@bib1]) (<http://www.blueprint-epigenome.eu>, Datasets EGAD00001002446, EGAX00001244028, EGAX00001244022 and EGAD00001002366) and analyzed the same way. Gene module enrichment was performed using tmod package ([@bib47]) and concordance and discordance was analyzed by calculating discordance scores ([@bib9]). Eosinophil gene sets were retrieved from Harmonizome ([@bib36]) and Broad Institute (<http://software.broadinstitute.org/gsea>, Nakajima set; [@bib31]), GATA-1 gene set was generated by associating GATA-1 ChIP seq peaks (GEO accession GSM1003608) to genes using ChIPseeker ([@bib50]).

Ex vivo differentiation of murine bone marrow cells into neutrophils and eosinophils {#s4-19}
------------------------------------------------------------------------------------

Murine bone marrow was extracted from the femurs and tibiae of adult age-matched mice. Cells were flushed, erythrocytes were lysed by osmotic lysis, cells were washed and lineage-negative precursor cells were sorted by negative selection using magnetic beads (130-110-470, Miltenyi Biotec). Lineage-negative cells were subsequently propagated analogous to the protocol described ([@bib6]). Briefly, cells were seeded in IMDM supplemented with 20% FCS, antibiotics, L-glutamine and 0.1 μM 2-mercaptoethanol (Sigma), as well as with the recombinant cytokines IL-3 (20 ng/ml), IL-5 (50 ng/ml), IL-9 (50 ng/ml), GM-CSF (10 ng/ml) and SCF (20 ng/ml) for 6 days.

Statistical analysis {#s4-20}
--------------------

The descriptive statistics of all figure panels are mentioned in the respective figure legends. Populations of circulating leukocytes in murine blood were compared by a two-tailed, unpaired t test and p values are indicated above the populations. RNA-seq data were analyzed as described in the respective methods section.
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Human subjects: Human primary neutrophils, PBMCs and monocytes were isolated from blood samples of healthy volunteers according to the declaration of Helsinki. All donors provided written informed consent and all blood samples were collected with approval from the local ethics committee.

Animal experimentation: Breeding of mice and isolation of blood and bone marrow were approved by the Berlin state authority Landesamt für Gesundheit und Soziales. All mice were bred at the Max Planck Insitute for Infection Biology under specific pathogen-free conditions. Animals were maintained on a 12-hour light/12-hour dark cycle and fed ad libitum.

Additional files {#s6}
================

###### List of sgRNA sequences, primer sequences and antibodies.

Individual sheets contain sequences of sgRNAs, sequencing primers, qRT-PCR primers and antibody catalog and lot numbers.

###### Key Resources table.

Table of reagents, cell lines, genetically modified organisms, others.

Data availability {#s7}
=================

RNA sequencing data have been deposited in ArrayExpress - accession no. E-MTAB-8459. All data generated or analysed during this study are included in the manuscript and supplementary files. Source data files are provided for Figure 1 and Figure 4. A supplementary file with all used qPCR primers, sgRNA sequences, antibodies and other reagents is provided.

The following dataset was generated:

SollbergerGStreeckRApelFCaffreyBESkoultchiAIZychlinskyA2020RNA-seq of human neutrophil-like cell line PLB-985 at various stages of differentiation with CRISPR knock-outs of H1 linker histonesArrayExpressE-MTAB-8459

The following previously published datasets were used:

Blueprint2016BP_August_2016_RNA-Seq_band_form_neutrophil_on_GRCh38 - samplesBlueprint DCCEGAD00001002446

Blueprint2016neutrophilic myelocyte from bone marrow of donor: BM230614, BM220513Blueprint DCCEGAX00001244028

Blueprint2016segmented neutrophil of bone marrow from bone marrow of donor: BM230614, BM220513Blueprint DCCEGAX00001244022

Blueprint2016BP_August_2016_RNA-Seq_neutrophilic_metamyelocyte_on_GRCh38 - samplesBlueprint DCCEGAD00001002366

NakajimaTMatsumotoKSutoHTanakaKEbisawaMTomitaHYukiKKatsunumaTAkasawaAHashidaRSugitaYOgawaHRaCSaitoH2001NAKAJIMA_EOSINOPHILMolecular Signatures DatabaseNAKAJIMA_EOSINOPHIL

ENCODE DCC2012Stanford_ChipSeq_K562_GATA1\_(SC-266)\_IgG-musNCBI Gene Expression OmnibusGSM1003608

van den BiggelaarM2019Dynamic transcriptome-proteome correlation networks reveal human myeloid differentiation and neutrophil-specific programmingProteomeXchangePXD013785
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The editors and reviewers want to highlight the importance of the CRISPR screen established here to identify components required for normal neutrophilic differentiation of PLB-985 cells. Your description of the novel role for histone H1 subtypes in regulating neutrophil-lineage specification and differentiation versus eosinophilic/basophilic lineages is highly novel.

**Decision letter after peer review:**

Thank you for submitting your article \"Linker Histone H1 subtypes specifically regulate neutrophil differentiation\" for consideration by *eLife*. Your article has been reviewed by Satyajit Rath as the Senior Editor, a Reviewing Editor, and two reviewers. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Sollberger et al., used a CRISPR screen to identify components required for normal neutrophilic differentiation of PLB-985 cells. They found that deletion of linker histones H1.2 and/or H1.4 reduced the differentiation of the cells towards a neutrophilic phenotype. Further experiments revealed that the absence of H1.2/H1.4 led to skewing of the cells towards GATA2-mediated differentiation to eosinophilic/basophilic lineages. Analysis of H1.2/H1.4 double knockout hematopoietic stem cells revealed that their in vitro differentiation was skewed towards eosinophils rather than neutrophils.

Essential revisions:

Both reviewers recognized interest and novelty in this study, describing a novel role for histone H1 subtypes in regulating neutrophil-lineage specification and differentiation in an in vitro differentiation setting. However, a major concern raised both at the first review and post-review by both reviewers as well as a major concern for the editor lies in the translation into a in vivo setting in mouse models or human cells. Indeed, no reduction in the circulating neutrophil counts in H1.2/H1.4 double knockout mice was observed, reducing the biological significance of the work beyond its technical novelty and could even suggest artifactual findings of the in vitro setting developed by the authors. The authors should perform an in depth analysis of bone marrow and blood levels (not percentage) of neutrophils in steady state and inflammation (for example repopulation after bone marrow transplant or marrow proliferating cell ablation or in a model of emergency granulopoiesis).

As previously mentioned, neutrophil lineage specification is determined by transcription factors such as CEBP-α or -- ε. How H1.2 and H1.4 function? Are CEBP-α or -- ε levels also altered in cells deficient for H1.2 and H1.4 or is it only dependent of GATA-2? Do cells deficient for H1.2 and H1.4 exhibit phenotypic and functional characteristics similar to eosinophils? Are these proteins expressed at low levels in primary eosinophils? Is GATA-2 upregulated in the bone marrow of mice deficient for H1.2 and H1.4?

\[Editors\' note: further revisions were suggested prior to acceptance, as described below.\]

Thank you for sending your article entitled \"Linker histone H1.2 and H1.4 affect the neutrophil lineage determination\" for peer review at *eLife*. Your article is being evaluated by Satyajit Rath as the Senior Editor, a Reviewing Editor, and two reviewers.

The essential point of discussion was the need to revise the analysis of age-young neutrophils based on CD62L expression (second question) to potentially support your hypothesis, plus additional major textual revisions. About the major textual revisions, we all recognized the value of the CRISPR screen in cell from the neutrophil-lineage which is a substantial achievement and the attempt to have made effort to add more in vivo relevance. However, the reviewers made the point that those experiments do not fit as logically into the manuscript as the original results and that the in vivo results are still confusing. Hence, we would also request to clarify the presentation and interpretation of the new data, with a more thorough and objective discussion on the fact that the major observation was made on a neutrophil cell line, that the in vivo confirmation needs further work and more discussion for the discrepancies found in this study (increase in circulating eosinophils but not with changes in neutrophil numbers, no differences in G-CSF level, lower amount of young neutrophils in the bone marrow...).

Please see below the comments that were raised in more details.

Reviewer \#1:

In this revision, Sollberger and colleagues provide new data to address the in vivo importance of histone H1 during neutrophil-lineage specification and differentiation by analyzing in depth granulopoiesis in H1.2/H1.4-deficient mice during homeostasis and inflammation. Interestingly, in homeostasis -not during casein-induced peritonitis- absolute numbers of eosinophils are increased in blood of mutant mice, which is agreement with the in vitro data. However, as observed in the initial manuscript, neutrophil absolute numbers are not affected (or even increased) both under steady state and during inflammation. The authors claim that altered cytokine profile involved in granulopoiesis (IL-17a) and neutrophil mobilization (CXCL1) and changes in neutrophil maturation (reduced number of young neutrophils and increased granularity) may explain these results observed in the H1.2/H1.4-deficient mice.

For the reviewer these statements are not clear:

\- First, no changes in G-CSF are found which could be associated to increase granulopoiesis that could compensate neutrophil numbers.

\- Second, a lack of neutrophils due to altered granulopoiesis in H1.2/H1.4-deficient mice should generate de novo production of neutrophils, hence observing increased levels of young neutrophils in the bone marrow, not decreasing.

Maybe I misunderstood but it is not clear to me how Figure 5---figure supplement 2B and 2C can be possible. If absolute numbers of neutrophils (2A) are not altered and the percentage of CD62l+ is not affected either, how in 2C are decreased. This concern also applies to graphs 2D-F. How CD62L percentage was calculated? The authors should show the plots of these results (not only the gating strategy).

\- According to Casanova-Acebes et al., (2013), aged neutrophils exhibit low granularity and size. If lower numbers of young neutrophils are found and hence more aged are present, a decreased in SSC and FSC should be seen. Not an increase.

\- How are the numbers of eosinophils in the bone marrow? This result is of key importance and it is not shown.

\- How are the levels of eosinophils in blood and bone marrow after casein treatment?

I agree with the authors that many confounding factors can influence the results in the mutant mice but still such results are key for the message of the paper. Based on the observed results, no strong effect of H1 subtypes is observed on neutrophil differentiation in homeostasis and during inflammation. Maybe such difference could have been seen during marrow regeneration (i.e. after 5-fluorouracil treatment).

Reviewer \#2:

This is an interesting work on a CRISPR screen on neutrophil-like cell lines identifying a role for linker histones on neutrophil differentiation.

The authors have appropriately addressed the reviewers\' and the editor\'s questions.

10.7554/eLife.52563.sa2

Author response

> Essential revisions:
>
> Both reviewers recognized interest and novelty in this study, describing a novel role for histone H1 subtypes in regulating neutrophil-lineage specification and differentiation in an in vitro differentiation setting. However, a major concern raised both at the first review and post-review by both reviewers as well as a major concern for the editor lies in the translation into a in vivo setting in mouse models or human cells. Indeed, no reduction in the circulating neutrophil counts in H1.2/H1.4 double knockout mice was observed, reducing the biological significance of the work beyond its technical novelty and could even suggest artifactual findings of the in vitro setting developed by the authors. The authors should perform an in depth analysis of bone marrow and blood levels (not percentage) of neutrophils in steady state and inflammation (for example repopulation after bone marrow transplant or marrow proliferating cell ablation or in a model of emergency granulopoiesis).

We thank the reviewers and the editor for their suggestions and we agree that a more detailed analysis of granulopoiesis is important. We analysed wild type and H1.2/H1.4-deficient animals during steady state and after Casein injection into the peritoneal cavity, which induces a peritonitis and leads to the influx of neutrophils (Amulic et al., 2017). In the new version of the manuscript, as suggested, we include counts of leukocytes rather than percentage (new Figure 5B,C, new Figure 5---figure supplement 2, Figure 5---figure supplement 3, Figure 5---figure supplement 4). We showed, as detailed below, two main changes in mice deficient in H1.2/H1.4; the dysregulation of cytokine/chemokine and a change in neutrophil ageing markers and granularity.

Importantly, we also found an increased number of circulating eosinophils at steady state in H1.2/H1.4-deficient animals (new Figure 5C). This is in line with our findings in human cells and shows that the loss of H1.2 and H1.4 affects the neutrophil/eosinophil lineage determination in vivo.

Interestingly, we found that both during steady state and upon casein injection, H1.2/H1/4-deficient mice produced altered amounts of cytokines and chemokines compared to wild type animals (new Figure 5---figure supplement 4H-L). Most prominently, H1.2/H1.4-deficient bone marrow cells transcribed less IL-6 and more CXCL1, the latter is an important neutrophil chemokine (new Figure 5 ---figure supplement 4H,I). We also found this upregulation of CXCL1 on the protein level in serum (new Figure 5---figure supplement 4J) and we further found enhanced production of IL-17 in the serum of casein-injected H1.2/H1.4-deficient mice compared to wild type animals (new Figure 5---figure supplement 4K). IL-17 is part of a feed forward loop leading to granulopoiesis (Stark et al., 2005) via the production of G-CSF, though we did not detect altered G-CSF levels in H1.2/H1.4-deficient animals (new Figure 5---figure supplement 4L). Taken together, our results indicate that granulopoiesis in H1-deficient animals is altered due to changes in cytokines and chemokines.

We further analysed the neutrophil population in H1.2/H1.4-deficient mice using a second panel of surface marker antibodies by flow cytometry (new Figure 5---figure supplement 1B). The combined use of CD62L and CXCR4 allows the analysis of young vs aged neutrophils (Adrover et al., 2019; Zhang et al., 2015) and we found reduced numbers of young neutrophils in the bone marrow of H1.2/H1.4-deficient animals (new Figure 5---figure supplement 4A-C) suggesting compensatory effects regulating neutrophil turnover in these mice.

Lastly, when we incubated bone marrow cells overnight in the presence or absence of G-CSF, we found that G-CSF induced increased survival in H1.2/H1.4-deficient cells compared to wild type cells (new Figure 5---figure supplement 5A). The H1-deficient bone marrow cells also were more granular than wild type cells after overnight incubation (new Figure 5---figure supplement 5B), indicating that the spontaneous degranulation is affected. Indeed, we also found H1.2/H1.4-deficient bone marrow neutrophils to be more granular than wild type cells (new Figure 5---figure supplement 5C,D). This would again be in line with a different ageing phenotype, since a recent publication showed spontaneous degranulation of neutrophils upon ageing (Adrover et al., 2020).

Taken together, we provide evidence of cytokine/chemokine dysregulation in H1-deficient mice, as well as a change in neutrophil ageing markers and granularity. We therefore think that our analysis of lineage negative stem cells isolated from bone marrow is an appropriate way of analysing the intrinsic differentiation capacity of H1-deficient cells in the absence of confounding factors.

> As previously mentioned, neutrophil lineage specification is determined by transcription factors such as CEBP-α or -- ε. How H1.2 and H1.4 function? Are CEBP-α or -- ε levels also altered in cells deficient for H1.2 and H1.4 or is it only dependent of GATA-2? Do cells deficient for H1.2 and H1.4 exhibit phenotypic and functional characteristics similar to eosinophils? Are these proteins expressed at low levels in primary eosinophils? Is GATA-2 upregulated in the bone marrow of mice deficient for H1.2 and H1.4?

The reviewers point that other transcription factors might also affect neutrophil vs eosinophil differentiation in our system, is, of course, interesting. Indeed, we found in our RNA-seq experiment that C/EBP-α levels are downregulated in PLB-985 deficient for H1.2 or H1.4 at the onset of differentiation (new Figure 4---figure supplement 2). In cells deficient for H1.1, H1.3 and H1.5 expression of C/EBP-α was enhanced at the onset of differentiation, which is in line with the fact that these cells showed accelerated maturation (new Figure 4---figure supplement 2). We subsequently analysed the expression of other C/EBP family transcription factors. C/EBP-α expression was enhanced in H1.2- and H1.4-deficient cells at later time points of differentiation, but not at early time points. We also found enhanced expression of other C/EBP family members, most prominently an upregulation of C/EBP-α and C/EBP-α in clones deficient for H1.1, H1.3 and H1.5 (new Figure 4---figure supplement 2). We therefore conclude that, besides GATA-1 and GATA-2, other transcription factors are differentially regulated.

To assess the expression levels of H1 subtypes in human primary eosinophils, we isolated RNA from these cells and performed qRT-PCR experiments. Surprisingly, expression levels of H1.2 and H1.4 were very high in primary eosinophils, much higher than in any other cell type we studied (new Figure 4---figure supplement 3E). This indicates that H1.2 and H1.4 levels are indeed crucial for adequate eosinophil differentiation. We assume that too high as well as too low expression of these subtypes affect the lineage determination of neutrophils and eosinophils.

When we analysed GATA expression in the bone marrow of H1.2/H1.4-deficient mice, we found that these animals showed enhanced expression of GATA-1, in line with what we found in PLB-985 (new Figure 6---figure supplement 1C). GATA-2 expression was neither changed in RNA isolated from total bone marrow nor in lineage negative stem cell RNA isolations (new Figure 6---figure supplement 1d), which could be due to the altered cytokine milieu in vivo. We also noted that in mice expression of GATA-1 was higher than of GATA-2 (new Figure 6---figure supplement 1C,D), opposite to what we had found in human cells. It could therefore be that the loss of H1.2 and H1.4 in mice more readily affects the higher expressed GATA-1.

Taken together, we provide evidence that, besides GATA transcription factors, C/EBP family transcription factors are also dysregulated in H1-deficient cells in human (new Figure 4---figure supplement 2) and mouse (new Figure 6---figure supplement 1E) and we show an effect of H1.2 and H1.4 deficiency on GATA-1 in vivo.

Regarding the question whether PLB-985 become eosinophils in the absence of H1.2 or H1.4, we believe that in PLB-985 cells, the loss of H1.2 or H1.4 affects eosinophil markers primarily on a transcriptional level, since H1.2- and H1.4-deficient clones remained viable and the cells divided at late stages of differentiation (Figure 3C-F). We did, however, analyse the morphology and function of PLB-985 to assess whether they became functional eosinophils. We did not observe specific eosinophil morphology of H1.2- or H1.4-deficient PLB-985 cells by transmission electron microscopy (TEM) (new Figure 4---figure supplement 3A). However, when we looked at eosinophil markers on the protein level, we did observe an increase in the expression of Siglec-8 on the surface of (new Figure 4---figure supplement 3B) H1.2- or H1.4-deficient cells and we also found enhanced expression of the eosinophil protein galectin-10/CLC (new Figure 4---figure supplement 3C,D). We therefore conclude that deficiency of H1.2 or H1.4 also induces upregulation of eosinophil proteins, without affecting the overall morphology of PLB-985.

> \[Editors\' note: further revisions were suggested prior to acceptance, as described below.\]
>
> The essential point of discussion was the need to revise the analysis of age-young neutrophils based on CD62L expression (second question) to potentially support your hypothesis, plus additional major textual revisions. About the major textual revisions, we all recognized the value of the CRISPR screen in cell from the neutrophil-lineage which is a substantial achievement and the attempt to have made effort to add more in vivo relevance. However, the reviewers made the point that those experiments do not fit as logically into the manuscript as the original results and that the in vivo results are still confusing. Hence, we would also request to clarify the presentation and interpretation of the new data, with a more thorough and objective discussion on the fact that the major observation was made on a neutrophil cell line, that the in vivo confirmation needs further work and more discussion for the discrepancies found in this study (increase in circulating eosinophils but not with changes in neutrophil numbers, no differences in G-CSF level, lower amount of young neutrophils in the bone marrow...).

We apologize for the apparent lack of clarity. We present our in vivo data in a more understandable way. Specifically, we rearranged Figure 5---figure supplement 4, Figure 5---figure supplement 5 to more figure panels with a better panel structure (new Figure 5---figure supplement 4, Figure 5---figure supplement 5, Figure 5---figure supplement 6, Figure 5---figure supplement 7). Moreover, we discuss the limitations of our study (Discussion section) and clearly state that more work will have to be done regarding the in vivo relevance of our findings.

> Please see below the comments that were raised in more details.
>
> Reviewer \#1:
>
> In this revision, Sollberger and colleagues provide new data to address the in vivo importance of histone H1 during neutrophil-lineage specification and differentiation by analyzing in depth granulopoiesis in H1.2/H1.4-deficient mice during homeostasis and inflammation. Interestingly, in homeostasis -not during casein-induced peritonitis- absolute numbers of eosinophils are increased in blood of mutant mice, which is agreement with the in vitro data. However, as observed in the initial manuscript, neutrophil absolute numbers are not affected (or even increased) both under steady state and during inflammation. The authors claim that altered cytokine profile involved in granulopoiesis (IL-17a) and neutrophil mobilization (CXCL1) and changes in neutrophil maturation (reduced number of young neutrophils and increased granularity) may explain these results observed in the H1.2/H1.4-deficient mice.
>
> For the reviewer these statements are not clear:
>
> \- First, no changes in G-CSF are found which could be associated to increase granulopoiesis that could compensate neutrophil numbers.

We thank the reviewer for acknowledging our new in vivo work. As the reviewer correctly points out, we did not detect changes in G-CSF (new Figure 5---figure supplement 6E) in homeostatic conditions or after injection of casein.

The levels of G-CSF in homeostatic conditions were very low. This means that, in homeostatic conditions, we are probably at the detection limit of the ELISA and cannot detect subtle differences if they exist. Upon an inflammatory stimulus, Casein, we detected G-CSF in circulation, but there were no differences between wild type and H1.2/H1.4 null mice.

It is relevant to point out that, while G-CSF is a major inducer of granulopoieses, this process is likely affected by other cytokines. Indeed, we observed changes in CXCL1 and IL17. We discuss the levels of G-CSF in H1.2/H1.4-deficient mice more critically in our revised manuscript on Discussion section.

> \- Second, a lack of neutrophils due to altered granulopoiesis in H1.2/H1.4-deficient mice should generate de novo production of neutrophils, hence observing increased levels of young neutrophils in the bone marrow, not decreasing.

We agree with the reviewer. However, we did see decreased levels of young (CD62L positive, CXCR4 negative) neutrophils (Figure 5---figure supplement 4C, new Figure 5---figure supplement 5). We discuss these findings (subsection "Enhanced eosinophil differentiation of H1.2/H1.4-deficient hematopoietic stem cells", Discussion section) and acknowledge that they do not fit with the expected paradigm.

> Maybe I misunderstood but it is not clear to me how Figure 5---figure supplement 2B and 2C can be possible. If absolute numbers of neutrophils (2A) are not altered and the percentage of CD62l+ is not affected either, how in 2C are decreased. This concern also applies to graphs 2D-F. How CD62L percentage was calculated? The authors should show the plots of these results (not only the gating strategy).

We think that the reviewer refers to Figure 5---figure supplement 4B and 4C. We apologize for the unclear plotting, 4B shows CD62L positive cells, whereas 4c shows CD62L positive and CXCR4 negative cells. We strongly believe that an inclusion of all individual flow cytometry plots to a supplementary figure (with 48 plots for Figure 5---figure supplement 4A-F alone) will make it impossible to understand the figure panels. Therefore, we rearranged our plots and we now include histograms of CD62L and CXCR4 expression where we overlay all animals as shown in our new Figure 5---figure supplement 5B,C,E,F.

> \- According to Casanova-Acebes et al., (2013), aged neutrophils exhibit low granularity and size. If lower numbers of young neutrophils are found and hence more aged are present, a decreased in SSC and FSC should be seen. Not an increase.

The reviewer is right to point out that ageing of neutrophils leads to reduces granularity, as also shown in 2020 by the same group (Adrover et al.,). Interestingly, the 2020 study by Adrover et al., also found changes of H1.2 and H1.4 on protein level as neutrophils aged. We cite this recent study and rephrase our wording in the manuscript (Discussion section). The fact that we find more neutrophils with ageing markers, but an enhanced survival and granularity after overnight incubation (new Figure 5---figure supplement 7) does not point towards an increase in ageing, but to a dysregulation of neutrophil behaviour, which we discuss in subsection "Enhanced eosinophil differentiation of H1.2/H1.4-deficient hematopoietic stem cells" and the Discussion section.

> \- How are the numbers of eosinophils in the bone marrow? This result is of key importance and it is not shown.
>
> \- How are the levels of eosinophils in blood and bone marrow after casein treatment?

We include eosinophil numbers in blood and bone marrow, during homeostasis and upon casein injection in our revised manuscript (new Figure 5---figure supplement 4).

> I agree with the authors that many confounding factors can influence the results in the mutant mice but still such results are key for the message of the paper. Based on the observed results, no strong effect of H1 subtypes is observed on neutrophil differentiation in homeostasis and during inflammation. Maybe such difference could have been seen during marrow regeneration (i.e. after 5-fluorouracil treatment).

We discuss our in vivo results more critically in the new version of the manuscript (Discussion section). The phenotypes we observed, as expected, are not strong. This is probably due to two reasons: first, we used animals deficient for, most likely, epigenetic modifiers rather than key transcription factors and, second, granulopoiesis is an important process that is regulated by feedback loops and via different cytokines. Another, third, reason could be that the compensatory effects are different or stronger upon deletion of two H1 subtypes in mouse versus the PLB-985, which are deficient for only one H1 subtype.

[^1]: Berlin Institute of Health (BIH), Berlin, Germany.

[^2]: Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
